Get Permission Singh: Our clinical evidence on infected burn wound healing with the bacteriophages-future revolution on the horizon


Respected Sir,

Done a lot of cases successfully in our place with bacteriophages in small nonhealing chronic wounds but its use in extensive infected burn wound healing is also encouraging. In fact, our clinical evidence of topical application of bacteriophages on extensive multi-drug resistant [MDR] bacterial infected burn wounds has been done for the first time and has never been reported in the literature.

Isolation of bacteriophages is obtained from about 100 ml of water specimens from river Ganga, hospital sewage and ponds in the lab. The purified phages at a concentration of 10­ to power 9 CFU/ml of bacteriophages which are suspended in normal saline and is used in topical wound infection.

The use of antiseptics like betadine, spirit, chlorhexidine, etc. is forbidden as it is detrimental to bacteriophages. After washing with normal saline, sterilized gauge pieces soaked with bacteriophages was applied on the wound surface topically. According to culture customized bacteriophages were prepared and some times cocktail of bacteriophages were used. Bacteriophages were supplied in sterilized falcon tubes and stored in freezer for long time without loosing potency. The topical application of a maximum of a 50 ml of 1x10 to power 5 CFU/ml of bacteriophages were used on resistant infected wounds on alternate days. We used customized bacteriophages prepared and filtered in the department of microbiology for culture resistant bacteria.1 No debridement or slough removal was done and slowly with time, necrotic slough disappeared with healing power of bacteriophages. During application, there was no evidence of a sudden rise in leucocytosis, fever or other adverse side effects. After every two weeks, blood levels of bacteriophages were determined, and a concentration of 1 ×105 CFU/mL was found.

All wounds irrespective of size healed[Figure 1]. The absence of significant scarring and formation of contracture without plastic surgical skin grafting may be attributed to anti-inflammatory and immunomodulatory properties of bacteriophages inspite of long duration of 4 to 5 months of conservative topical treatment.2

Figure 1

Bacteriophage healed the MDR infected burn wound in 5 months

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/99b93cff-b23e-4471-a2e1-fea2fea4e1feimage1.png

The advantages of bacteriophages over antibiotics is quick, simple and inexpensive isolation. Bacteria becoming resistant to it is ten times less than to antibiotics. It is specific to pathogens, and resistance usually develops after 3 weeks, but there are at least more than 600 bacteriophages for one bacteria. They don’t affect human cells and so safe.3, 4

Bacteriophages is going to bring Medical revolution for treating superbugs and will have positive effect on economy creating huge global social impact.5

Acknowledgement

I am really thankful to Sulekha Singh, Gopal Nath and Rajesh Kumar for providing necessary help.

Conflict of Interest

None.

References

1 

DR Patel SK Bhartiya R Kumar VK Shukla G Nath Use of customized bacteriophages in the treatment of chronic nonhealing wounds: a prospective studyInt J Low Extrem Wounds2021201374610.1177/1534734619881076

2 

M Cafora A Brix F Forti N Loberto M Aureli F Briani Phages as immunomodulators and their promising use as anti-inflammatory agents in a cftr loss-of-function zebrafish modelJ Cyst Fibros202120610465210.1016/j.jcf.2020.11.017

3 

SK Bhartiya R Prasad S Sharma VK Shukla G Nath R Kumar Biological Therapy on Infected Traumatic Wounds: A Case-Control StudyInt J Low Extrem Wounds20211534734621107277910.1177/15347346211072779

4 

LB Aghaee MY Alikhani WB van Leeuwen A Mojtahedi S Kazemi P Karami Conventional Treatment of Burn Wound Infections versus Phage TherapyIran J Med Microbiol20221631869610.30699/ijmm.16.3.186

5 

S Singh Clinical evidence based nano crystalline silver dressing rationality, efficacy and strategy in extensive burn patients survivalIP Indian J Clin Exp Dermatol2020632687310.18231/j.ijced.2020.054



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

Article History

Received : 02-10-2022

Accepted : 08-11-2022


View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijced.2022.056


Article Metrics






Article Access statistics

Viewed: 1034

PDF Downloaded: 331